Los Angeles, CA, United States of America

Myungshin Oh

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Myungshin Oh: Innovator in Pharmacokinetic Drug Dosing Regimens

Introduction

Myungshin Oh is a notable inventor based in Los Angeles, CA (US). He has made significant contributions to the field of pharmacokinetics, particularly in drug dosing regimens. With a total of 3 patents to his name, his work has the potential to greatly impact patient care and treatment outcomes.

Latest Patents

Myungshin Oh's latest patents include innovative methods and apparatuses for providing pharmacokinetic drug dosing regimens. One of his patents focuses on systems and methods for providing a clotting factor VIII dosing regimen. This involves determining an estimated pharmacokinetic profile of a patient using a Bayesian model based on profiles of sampled patients. The system can establish a first dosing regimen that includes a first dosage and a therapeutic plasma protein level that varies over time. Additionally, it allows for adjustments based on previous patient treatments, ensuring that the protein level does not fall below a target trough. Another patent outlines a method for determining CFVIII clearance based on blood samples collected after an infusion, which helps in establishing a dosing regimen tailored to the patient's pharmacokinetic profile.

Career Highlights

Throughout his career, Myungshin Oh has worked with prominent companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in pharmacokinetics and drug dosing.

Collaborations

Myungshin Oh has collaborated with several professionals in his field, including Kameswara Rao Kuchimanchi and Alexandra Loew-Baselli. These collaborations have likely enriched his research and development efforts.

Conclusion

Myungshin Oh's innovative work in pharmacokinetic drug dosing regimens showcases his commitment to improving patient care through scientific advancements. His contributions are paving the way for more effective treatment strategies in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…